×
ReShape Lifesciences EBITDA 2015-2024 | RSLS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
ReShape Lifesciences ebitda from 2015 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
ReShape Lifesciences EBITDA 2015-2024 | RSLS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
ReShape Lifesciences ebitda from 2015 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$233.1B
Intuitive Surgical (ISRG)
$171.3B
Alcon (ALC)
$47.7B
IQVIA Holdings (IQV)
$44.2B
IDEXX Laboratories (IDXX)
$42.1B
Edwards Lifesciences (EW)
$40.7B
DexCom (DXCM)
$27.8B
STERIS (STE)
$23.5B
SONOVA HOLDING (SONVY)
$20.8B
Waters (WAT)
$19.8B
Hologic (HOLX)
$19B
Sysmex ADR (SSMXY)
$12.3B
Fresenius Medical Care AG KGaA (FMS)
$12.2B
Teleflex (TFX)
$11.4B
Globus Medical (GMED)
$9.4B
Penumbra (PEN)
$7.6B
Glaukos (GKOS)
$6.7B
Masimo (MASI)
$6.1B
TransMedics (TMDX)
$5.2B
PROCEPT BioRobotics (PRCT)
$4.3B
Integer Holdings (ITGR)
$4.3B
Tandem Diabetes Care (TNDM)
$2.8B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.6B
Inari Medical (NARI)
$2.6B
Elekta AB (EKTAY)
$2.6B
Nihon Kohden (NHNKY)
$2.5B
RxSight (RXST)
$2B
Integra LifeSciences Holdings (IART)
$1.4B
Pulse Biosciences (PLSE)
$1.2B